Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer

Recruiting now · Not applicable

Conditions studied: Head & Neck Cancer

In brief

The purpose of this study is to evaluate the diagnostic performance of 18F-FDG micro-PET-CT in malignant Head and neck cancer compared to definitive histological analysis (gold standard).

Key facts

Study ID

NCT07285564

Run by

Centre Henri Becquerel

People needed

10

Starts

2025-11-07

Expected to finish

2026-06-15

Last updated by the study team

2025-12-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed informed consent
• Adult, male or female, aged 18 or over
• Patient with a malignant tumor of the oral cavity, oropharynx, hypopharynx, larynx, sinuses, or salivary glands, regardless of lymph node status (any N) M0, operable
• Member or beneficiary of a social security plan

You may not qualify if…

• Child-Pugh C liver failure
• Patients under guardianship, conservatorship, or legal protection
• Patients deprived of their liberty
• Pregnant or breastfeeding women
• Hypersensitivity to 18F-FDG or any of its excipients (ethanol or water for injection)
• Uncontrolled diabetes
• Moderate to end-stage renal failure, stage IIIB to V (glomerular filtration rate less than 44 mL/min/1.73 m²)
• Patients unable to understand the study for any reason or to comply with the trial requirements (language, psychological, or geographical issues).

Where it is running

• Centre Henri Becquerel — Rouen, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.